The largest database of trusted experimental protocols

Celltitre glo cell viability assay

Manufactured by Promega
Sourced in United States

The CellTiter-Glo cell viability assay is a reagent-based luminescent assay that quantifies the amount of ATP present in metabolically active cells. The assay measures the light signal generated from the luciferase reaction, which is proportional to the amount of ATP and can be used to determine the number of viable cells in a sample.

Automatically generated - may contain errors

3 protocols using celltitre glo cell viability assay

1

Assessment of PLA2G7 Silencing Effects

Check if the same lab product or an alternative is used in the 5 most similar protocols
The effects of PLA2G7 silencing on cancer cell viability and induction of apoptosis were assessed with the CellTitre‐Glo cell viability assay and ApoONE apoptosis assay (Promega Inc, Madison, WI, USA) according to the manufacturer's instructions. The EnVision multilabel plate reader (Perkin‐Elmer, Waltham, MA) was used for signal quantification. Scrambled siRNA or shRNA was used as the negative control and KIF11 siRNA as the positive control.
+ Open protocol
+ Expand
2

Doxycycline-Hydroxyurea Cell Viability Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cells were seeded in 96-well plates at a density of 2500 cells per well over night. Next day (day 0), the medium was changed with a fresh medium with or without 2 μg/ml doxycycline. After 24 h of doxycycline treatment (day 1), the medium was changed again with fresh medium containing serially diluted hydroxyurea with or without doxycycline. At day 4, the cell viability was assessed using the CellTitre-Glo cell viability assay kit (Promega, Cat. # G7572) using PHERAstar FSX (BMG Labtech, San Diego, California).
+ Open protocol
+ Expand
3

Knockdown of EZH2 in Leukemia Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Two shRNA encoding oligonucleotides targeting EZH2 (shEZH2_1: 5' -GAGAGATTATTTCTCAAGATG-3'; shEZH2_2: 5' -TGGAAAGAACGGAAATCTTAA -3'), or a non-targeting control shRNA (Sigma-Aldrich, St. Louis, MO, USA) were inserted between AgeI and EcoRI restriction sites into plasmid pLKO.1 (Sigma).
Expression constructs were transduced and selected in cell lines F-36P (ACC-543), MOLM-13 (ACC-554) and OCI-M2 (ACC-619), purchased from The Leibniz Institute DSMZ -German Collection of Microorganisms and Cell Cultures GmbH, as described previously 16 and tested for mycoplasma contamination. Growth curves of cell lines were generated using the CellTitre-Glo cell viability assay (PROMEGA, Fitchburg, WI, USA), according to manufacturer instructions.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!